Research Site

Butler, Pennsylvania 16001

2 studies enrolling now · 6 studies all time

What they study most

APOL1-Mediated Kidney Disease, Acute Coronary Syndrome, Carcinoma, Chronic Kidney Disease and Hypertension, Diabetes Mellitus, Type 2, Heart Failure, Metastases, Neoplasm, Non-small-cell Lung

Studies at this site

• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure — Recruiting now
• Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease — Recruiting now
• Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS — Completed
• Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction — Completed
• A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus — Completed
• Iressa Expanded Access Program (EAP) — Completed